# Inovium Ovarian Rejuvenation Trials

> **NCT03178695** · PHASE1 · COMPLETED · sponsor: **Ascendance Biomedical** · enrollment: 200 (actual)

## Conditions studied

- Perimenopausal Disorder
- Menopause
- Menopause, Premature
- Menopause Related Conditions
- Menopause Premature Symptomatic
- Menopause Premature Asymptomatic
- Premature Ovarian Failure
- Premature Ovarian Failure, Familial
- Premature Ovarian Failure 2A
- Premature Ovarian Failure 3
- Premature Ovarian Failure 4
- Premature Ovarian Failure 1
- Premature Ovarian Failure 5
- Premature Ovarian Failure 6
- Premature Ovarian Failure 7
- Premature Ovarian Failure 9
- Premature Ovarian Failure 8
- Infertility
- Infertility, Female
- Infertility Unexplained

## Interventions

- **OTHER:** Autologous PRP injection into human ovarian tissue

## Key facts

- **NCT ID:** NCT03178695
- **Lead sponsor:** Ascendance Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178695, "Inovium Ovarian Rejuvenation Trials". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03178695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*